Pharsight

CRYSTAL PHARMATECH patents facing oppositions

Top patents of CRYSTAL PHARMATECH facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3071554B1 Crystalline forms of lesinurad and its sodium salt NA 1
EP3231805B1 04 Mar, 2020 Salt of pyrrolo[2,3-d]pyrimidine compound and novel polymorph of salt Dec, 2035 1
EP3229799B1 17 Oct, 2018 Crystalline forms of trisodium supramolecular complex comprising valsartan and ahu-377 and methods thereof NA 1